- Recent news on Respiratory Syncytial Virus (RSV) includes12345:
- The Food and Drug Administration approved a new kind of immunization to protect babies from RSV, called nirsevimab1.
- The Centers for Disease Control and Prevention issued a health advisory last month that RSV is unexpectedly spreading in Southern states2.
- Annual outbreaks of RSV occur in the late fall through early spring months, but in 2022, outbreaks began earlier than usual3.
- The U.S. Food and Drug Administration approved Arexvy, the first RSV vaccine approved for use in the United States, for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older4.
- In the most recent fortnightly data release, 6,356 infections were reported across the country. Most cases were in children aged four or younger5.
Learn more:✕This summary was generated using AI based on multiple online sources. To view the original source information, use the "Learn more" links.The Food and Drug Administration announced Monday it had approved a new kind of immunization to protect babies from RSV, or respiratory syncytial virus. The drug, nirsevimab, is one of two new options doctors hope could soon prevent the leading cause of hospitalization facing American infants.www.cbsnews.com/news/fda-approves-drug-protec…The Centers for Disease Control and Prevention issued a health advisory last month that respiratory syncytial virus, or RSV, is unexpectedly spreading in Southern states. RSV, which usually spikes during winter, can cause severe illness in kids and older adults and kills up to 500 children under age 5 each year.www.nbcnews.com/health/kids-health/rsv-spreadin…Annual outbreaks of RSV occur in the late fall through early spring months, but in 2022, outbreaks began earlier than usual. The Centers for Disease Control (CDC) has issued a health advisory regarding higher instances of the virus and stressing the importance of preventative measures.caromonthealth.org/news/respiratory-syncytial-viru…Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.www.fda.gov/news-events/press-announcements/f…In the most recent fortnightly data release, 6,356 infections were reported across the country. That's a slight increase from the previous fortnight, when 6,292 cases were reported. The database also shows that most cases were in children aged four or younger: that's 19,641 cases for 2023 to May 12, out of 32,259 total cases — almost two-thirds.www.abc.net.au/news/2023-05-15/what-is-rsv-sym… - People also ask
RSV vaccine for infants coming to parts of Canada this fall | CTV …
WEB12 hours ago · His son had respiratory syncytial virus, or RSV — a common illness with often mild symptoms in children and adults. But for infants and seniors, RSV is a major …
FDA approves first vaccine for RSV, a moment six …
WEBMay 3, 2023 · After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV – and more are on …
- Estimated Reading Time: 8 mins
New images of RSV may expose stubborn virus's weak points
WEB9 hours ago · Oct. 26, 2023 — A new study helps to identify children who are at the highest risk of a severe respiratory syncytial virus (RSV) infection and who would thus benefit …
What to know about RSV, a virus surging among young children …
WEBOct 26, 2022 · Respiratory syncytial virus (RSV) causes infections of the lungs and respiratory tract. It can result in severe infection in some people, including babies under two and older adults with...
- Author: Benjamin Shingler
How to access the new RSV vaccine, and how much …
WEBDec 10, 2023 · Arexvy is the first vaccine given the green light by Health Canada to protect against respiratory syncytial virus or RSV in adults over 60.
‘A good day’: FDA approves world’s first RSV vaccine
WEBMay 3, 2023 · The US Food and Drug Administration (FDA) has approved GSK’s vaccine against respiratory syncytial virus (RSV) for use in people aged 60 years and older. This is the first RSV vaccine to gain...
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
WEBMay 4, 2023 · Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy …
Progress at last against RSV - Nature Medicine
WEBSep 14, 2023 · A surge in respiratory syncytial virus (RSV) infections and RSV-related hospitalizations in the 2023 Southern Hemisphere winter, similar to that seen in 2022 in …
RSV in adults: Canada approves vaccine | CTV News
WEBAug 4, 2023 · Health Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over, but its use may be "limited" during this fall's …
Respiratory syncytial virus | RSV symptoms in older adults
AdGet the facts. RSV can lead to pneumonia or worsen the symptoms of chronic illnesses. Learn more about the respiratory syncytial virus (RSV) and its symptoms.
Skip to content
